32. F<strong>le</strong>isher, B., et al., Lung profi<strong>le</strong>: sex differences in normal pregnancy. Obstet Gynecol, 1985. 66(3): p. 327-30.33. Perelman, R.H., et al., Fetal lung <strong>de</strong>velopment in ma<strong>le</strong> and fema<strong>le</strong> nonhuman primates. Pediatr Res, 1986.20(10): p. 987-91.34. Bland, R.D. and D.W. Nielson, Developmental changes in lung epithelial ion transport and liquid movement.Annu Rev Physiol, 1992. 54: p. 373-94.35. Khan, P.A., M. Cloutier, and B. Piedboeuf, Tracheal occlusion: a review of obstructing fetal lungs to makethem grow and mature. Am J Med Genet C Semin Med Genet, 2007. 145C(2): p. 125-38.36. Alcorn, D., et al., Morphological effects of chronic tracheal ligation and drainage in the fetal lamb lung. JAnat, 1977. 123(Pt 3): p. 649-60.37. Moessinger, A.C., et al., Ro<strong>le</strong> of lung fluid volume in growth and maturation of the fetal sheep lung. J ClinInvest, 1990. 86(4): p. 1270-7.38. O'Brodovich, H.M., Immature epithelial Na+ channel expression is one of the pathogenetic mechanisms<strong>le</strong>ading to human neonatal respiratory distress syndrome. Proc Assoc Am Physicians, 1996. 108(5): p. 345-55.39. Johnson, M.D., et al., Alveolar epithelial type I cells contain transport proteins and transport sodium,supporting an active ro<strong>le</strong> for type I cells in regulation of lung liquid homeostasis. Proc Natl Acad Sci U S A,2002. 99(4): p. 1966-71.40. Farman, N., et al., Noncoordinated expression of alpha-, beta-, and gamma-subunit mRNAs of epithelialNa+ channel along rat respiratory tract. Am J Physiol, 1997. 272(1 Pt 1): p. C131-41.41. Yue, G., et al., Increased expression and activity of sodium channels in alveolar type II cells of hyperoxicrats. Proc Natl Acad Sci U S A, 1995. 92(18): p. 8418-22.42. Talbot, C.L., et al., Quantitation and localization of ENaC subunit expression in fetal, newborn, and adultmouse lung. Am J Respir Cell Mol Biol, 1999. 20(3): p. 398-406.43. Papageorgiou, A.N., et al., Inci<strong>de</strong>nce of respiratory distress syndrome following antenatal betamethasone:ro<strong>le</strong> of sex, type of <strong>de</strong>livery, and prolonged rupture of membranes. Pediatrics, 1981. 67(5): p. 614-7.44. Perelman, R.H., et al., Discordance between ma<strong>le</strong> and fema<strong>le</strong> <strong>de</strong>aths due to the respiratory distresssyndrome. Pediatrics, 1986. 78(2): p. 238-44.45. Martin, J.A., et al., Births: final data for 2004. Natl Vital Stat Rep, 2006. 55(1): p. 1-101.46. Shanklin, D.R., The sex of premature infants with hyaline membrane disease. South Med J, 1963. 56: p.1018-22.47. Torday, J.S., Androgens <strong>de</strong>lay human fetal lung maturation in vitro. Endocrinology, 1990. 126(6): p. 3240-4.48. Rodriguez, A., R.M. Viscardi, and J.S. Torday, Fetal androgen exposure inhibits fetal rat lung fibroblast lipiduptake and re<strong>le</strong>ase. Exp Lung Res, 2001. 27(1): p. 13-24.51
49. Nielsen, H.C., H.M. Zinman, and J.S. Torday, Dihydrotestosterone inhibits fetal rabbit pulmonary surfactantproduction. J Clin Invest, 1982. 69(3): p. 611-6.50. Labrie, F., et al., Intracrinology: ro<strong>le</strong> of the family of 17 beta-hydroxysteroid <strong>de</strong>hydrogenases in humanphysiology and disease. J Mol Endocrinol, 2000. 25(1): p. 1-16.51. Lukacik, P., K.L. Kavanagh, and U. Oppermann, Structure and function of human 17beta-hydroxysteroid<strong>de</strong>hydrogenases. Mol Cell Endocrinol, 2006. 248(1-2): p. 61-71.52. Wu, X., et al., SDR-type human hydroxysteroid <strong>de</strong>hydrogenases involved in steroid hormone activation.Mol Cell Endocrinol, 2007. 265-266: p. 71-6.53. Mindnich, R., G. Mol<strong>le</strong>r, and J. Adamski, The ro<strong>le</strong> of 17 beta-hydroxysteroid <strong>de</strong>hydrogenases. Mol CellEndocrinol, 2004. 218(1-2): p. 7-20.54. Peltoketo, H., et al., 17beta-hydroxysteroid <strong>de</strong>hydrogenase (HSD)/17-ketosteroid reductase (KSR) family;nomenclature and main characteristics of the 17HSD/KSR enzymes. J Mol Endocrinol, 1999. 23(1): p. 1-11.55. Russell, D.W. and J.D. Wilson, Steroid 5 alpha-reductase: two genes/two enzymes. Annu Rev Biochem,1994. 63: p. 25-61.56. Payne, A.H. and D.B. Ha<strong>le</strong>s, Overview of steroidogenic enzymes in the pathway from cho<strong>le</strong>sterol to activesteroid hormones. Endocr Rev, 2004. 25(6): p. 947-70.57. Simard, J., et al., Mo<strong>le</strong>cular biology of the 3beta-hydroxysteroid <strong>de</strong>hydrogenase/<strong>de</strong>lta5-<strong>de</strong>lta4 isomerasegene family. Endocr Rev, 2005. 26(4): p. 525-82.58. Penning, T.M., et al., Structure-function of human 3 alpha-hydroxysteroid <strong>de</strong>hydrogenases: genes andproteins. Mol Cell Endocrinol, 2004. 215(1-2): p. 63-72.59. Penning, T.M., et al., I<strong>de</strong>ntification of the mo<strong>le</strong>cular switch that regulates access of 5alpha-DHT to theandrogen receptor. Mol Cell Endocrinol, 2007. 265-266: p. 77-82.60. Bel<strong>le</strong>mare, V., F. Labrie, and V. Luu-The, Isolation and characterization of a cDNA encoding mouse 3alphahydroxysteroid<strong>de</strong>hydrogenase: an androgen-inactivating enzyme se<strong>le</strong>ctively expressed in fema<strong>le</strong> tissues. JSteroid Biochem Mol Biol, 2006. 98(1): p. 18-24.61. Provost, P.R., et al., Androgen formation and metabolism in the pulmonary epithelial cell line A549:expression of 17beta-hydroxysteroid <strong>de</strong>hydrogenase type 5 and 3alpha-hydroxysteroid <strong>de</strong>hydrogenase type 3.Endocrinology, 2000. 141(8): p. 2786-94.62. Provost, P.R., et al., Androgen inactivation in human lung fibroblasts: variations in <strong>le</strong>vels of 17 betahydroxysteroid<strong>de</strong>hydrogenase type 2 and 5 alpha-reductase activity compatib<strong>le</strong> with androgen inactivation. JClin Endocrinol Metab, 2002. 87(8): p. 3883-92.63. Provost, P.R., M. Simard, and Y. Tremblay, A link between lung androgen metabolism and the emergenceof mature epithelial type II cells. Am J Respir Crit Care Med, 2004. 170(3): p. 296-305.52
- Page 7 and 8: REMERCIEMENTSBien que leurs noms ne
- Page 9 and 10: INTRODUCTIONAu cours des dernières
- Page 11 and 12: L’influence de la prématurité e
- Page 13 and 14: INTRODUCTIONL’accouchement préma
- Page 15 and 16: Tableau 2Statistiques de survie des
- Page 17 and 18: indiquent que l’obésité réduir
- Page 19 and 20: Tableau 5Percentiles des poids (g)
- Page 21 and 22: détresse respiratoire que les peti
- Page 23 and 24: confirmée par plusieurs autres ess
- Page 25 and 26: Références1. Reed DM, Stanley FJ:
- Page 27 and 28: 32. Honest H, Bachmann LM, Ngai C,
- Page 29 and 30: L’influence de la prématurité e
- Page 31 and 32: laboratoire du Dr Yves Tremblay. El
- Page 33 and 34: Introductionlusieurs paramètres pe
- Page 35 and 36: Le canal artériel crée une joncti
- Page 37 and 38: Figure 1. Histologie du poumon de s
- Page 39 and 40: cette variation allélique. D’aut
- Page 41 and 42: Chez le rat, la DHT réduit, dans d
- Page 43 and 44: les mécanismes subtils de la matur
- Page 45 and 46: Signaux de communication entre le m
- Page 47 and 48: FONDEMENTS BIOMÉDICAUX DES THÉRAP
- Page 49 and 50: L’OCCLUSION TRACHÉALECette techn
- Page 51: 16. Derin, B.G., et al., Immunohist
- Page 55 and 56: 80. Bahasadri, S. and N. Changizi,
- Page 57 and 58: 111. Tremblay, L.O., et al., Respir
- Page 59 and 60: L’influence de la prématurité e
- Page 61 and 62: INTRODUCTIONAlors que les médias n
- Page 63 and 64: scolaire professionnelle et ils ont
- Page 65 and 66: l’âge de 6 ans présenteraient a
- Page 67 and 68: S’il s’agit en plus d'un enfant
- Page 69 and 70: RÉFÉRENCES1. O'Shea TM, Kuban KC,
- Page 71 and 72: 31. Garel M, Bahuaud M, Blondel B:
- Page 73 and 74: PRÉSENTATION DE L'AUTEUREMireille
- Page 75 and 76: non) et selon les décisions prises
- Page 77 and 78: L’ÊTRE HUMAIN ET LA SÉLECTION N
- Page 79 and 80: pratiques aient évolué depuis ce
- Page 81 and 82: survivants soient disponibles, des
- Page 83 and 84: de certitude scientifique sur les r
- Page 85 and 86: LA PLACE DES PARENTSPlusieurs group
- Page 87 and 88: l’équipe soignante. Dans ces mom
- Page 89 and 90: ANNEXE 1Définitions de concepts cl
- Page 91 and 92: 17. Chervenak, F. A., McCullough, L
- Page 93 and 94: REMERCIEMENTS DE LA PART DE L'AUTEU
- Page 95 and 96: INTRODUCTIONÀ mesure que les progr
- Page 97 and 98: dans l’affaire Tremblay c. Daigle
- Page 99 and 100: La viabilité est conditionnelle à
- Page 101 and 102: consentement aux soins du prématur
- Page 103 and 104:
libre et éclairé 52 ;Nul ne peut
- Page 105 and 106:
sont uniques selon son âge et sa c
- Page 107 and 108:
18 Tremblay c. Daigle, [1989] 2 R.C
- Page 109 and 110:
45 Robert P.KOURI, Suzanne PHILIPS-
- Page 111 and 112:
L’influence de la prématurité e
- Page 113 and 114:
critères de nature clinique et ép
- Page 115 and 116:
qualité de vie acceptable. Ainsi,
- Page 117 and 118:
RÉFÉRENCESOuvrages générauxVers